Table 1.
Comparison of baseline data between the poor prognosis group and the good prognosis group.
| Indicator | Group | χ2/t/Z | P value | |
|---|---|---|---|---|
| Good (mRS 0–2) (n = 46) | Poor (mRS 3–6) (n = 31) | |||
| Clinical data | ||||
| Sex | ||||
| Male | 33(71.74) | 16(51.61) | 3.242 | 0.072 |
| Female | 13(28.26) | 15(48.39) | ||
| Age, years | 59.13 ± 16.23 | 71.45 ± 13.77 | − 3.467 | 0.001 |
| BMI, kg/m2 | 24.43 ± 4.14 | 23.38 ± 3.85 | 1.087 | 0.281 |
| APACHE II | 9.61 ± 4.96 | 15 ± 5.2 | − 4.584 | < 0.001 |
| CCI | 0.43 ± 0.75 | 1.48 ± 1.36 | − 3.905 | < 0.001 |
| NRS2002 | 2.87 ± 2.01 | 5.13 ± 2 | − 4.856 | < 0.001 |
| Diagnosis (classification) | ||||
| Cerebrovascular diseases | 31(67.39) | 21(67.74) | / | > 0.999 |
| CNS infectious diseases | 5(10.87) | 3(9.68) | ||
| Neuromyelitis optica | 1(2.17) | 1(3.23) | ||
| Epilepsy | 7(15.22) | 4(12.90) | ||
| Metabolic encephalopathy | 1(2.17) | 1(3.23) | ||
| Degenerative diseases of the nervous system | 1(2.17) | 1(3.23) | ||
| Previous history of neurological diseases | ||||
| No | 41(89.13) | 28(90.32) | / | > 0.999 |
| Yes | 5(10.87) | 3(9.68) | ||
| Inflammatory indicators within the first day of admission | ||||
| WBC, *109/L | 9.63 ± 3.12 | 10.77 ± 4.72 | − 1.181 | 0.244 |
| ANC, *109/L | 7.78 ± 3.12 | 8.56 ± 3.87 | − 0.98 | 0.33 |
| ALC, *109/L | 1.22 ± 0.55 | 0.99 ± 0.51 | 1.806 | 0.075 |
| AMC, *109/L | 0.55 ± 0.23 | 0.61 ± 0.44 | − 0.766 | 0.448 |
| PLT, *109/L | 208.96 ± 71.23 | 184.45 ± 60.1 | 1.574 | 0.12 |
| NLR | 8.62 ± 7.44 | 10.57 ± 6.77 | − 1.171 | 0.245 |
| PLR | 196.58 ± 103.67 | 217.98 ± 106.03 | − 0.876 | 0.384 |
| hsCPR, mg/L | 5.22(2.46,10.87) | 14.91(6.21,20) | − 3.317 | 0.001 |
| Nutritional biochemical indicators | ||||
| Alb(on admission), g/L | 39.67 ± 5.02 | 37.32 ± 5.88 | 1.865 | 0.066 |
| Hb(on admission), g/L | 140.57 ± 16.48 | 127.29 ± 24.69 | 2.625 | 0.012 |
| Hb(on admission)-Hb(min), g/L | 9.5(5,20) | 35(6,59) | 3.166 | 0.002 |
| Glu(on admission), mmol/L | 6.5(5.4,8.9) | 7.9(6.5,8.7) | 1.369 | 0.171 |
| BIA indicators within the first day of admission | ||||
| BCM, kg | 30.54 ± 5.1 | 27.1 ± 5.8 | 2.659 | 0.01 |
| PA, degree | 5.57 ± 0.86 | 4.06 ± 0.93 | 7.077 | < 0.001 |
| BCM/PA, kg/degree | 5.53 ± 0.83 | 6.89 ± 1.64 | − 4.04 | < 0.001 |
| ICW, L | 21.33 ± 3.56 | 18.92 ± 4.06 | 2.663 | 0.01 |
| ECW, L | 13.27 ± 2.07 | 12.53 ± 2.41 | 1.396 | 0.167 |
| TBW, % | 0.38 ± 0.01 | 0.4 ± 0.01 | − 6.733 | < 0.001 |
| FFM, kg | 46.97 ± 7.57 | 42.57 ± 8.65 | 2.287 | 0.025 |
| TBW/FFM, % | 73.64 ± 0.38 | 73.79 ± 0.37 | − 1.722 | 0.089 |
| SMI, kg/m2 | 9.55 ± 1.32 | 8.53 ± 1.62 | 2.929 | 0.005 |
| WBP, kg | 9.21 ± 1.54 | 8.18 ± 1.75 | 2.649 | 0.01 |
| VFA, cm2 | 93.9 ± 49.57 | 118.33 ± 63.64 | − 1.834 | 0.071 |
| Outcome indicators | ||||
| Mortality rate within 3 months | ||||
| Survival | 46(100.00) | 15(48.39) | 29.969 | < 0.001 |
| Death | 0(0.00) | 16(51.61) | ||
| Mechanical ventilation time, days | 0(0,0) | 6(0,13) | 4.597 | < 0.001 |
| NICU hospital stay, days | 4(2,10) | 13(7,23) | 4.551 | < 0.001 |
| Total hospital stay, days | 15.5(13,25) | 25(13,37) | 1.763 | 0.078 |
| Hospitalization expenses, thousand yuan | 29.15(20.11,69.84) | 112.97(56.2,192.59) | 4.072 | < 0.001 |
Cerebrovascular diseases which include ischemic stroke, intracerebral hemorrhage; CNS infectious diseases = Central nervous system infection diseases, CNS infectious diseases which include N-methyl-D-aspartate receptors, tuberculous meningitis, viral encephalitis, toxoplasma encephalitis, purulent meningitis; Degenerative diseases of the nervous system which include parkinson's disease, Alzheimer's disease.